Sonoma BioTherapeutics
Sonoma BioTherapeutics
sonomabio.com

Locations

South San Francisco, CA, USA

industry

Biotechnology · DeepTech · Health

Size

51-200 employees

Stage

Other

founded in

2020

Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approaches to develop a new generation of targeted Treg cell therapies designed to induce durable immune tolerance to treat and prevent autoimmune and inflammatory diseases. Sonoma Biotherapeutics is based in South San Francisco and Seattle.

Something looks off?
Open jobs at Sonoma BioTherapeutics

On-site & Remote